# Contact PT-141 Safe: Editorial and Correction Inquiries

> Contact PT-141 Safe with editorial questions or corrections about our PT-141 (bremelanotide) coverage. An editorial project — not a clinic, not a vendor, no prescriptions.

Editorial questions and corrections only. We do not prescribe, sell, or source PT-141 (bremelanotide).

## Editorial and corrections

PT-141 Safe is an editorial datasheet on PT-141 (bremelanotide), and the contact channel is for editorial matters only. If you spot an error — a miscited study, an out-of-date figure, a claim that needs a clearer source — we want to know. Accuracy is the whole point of a datasheet, and corrections from careful readers make it better.

Use the form below to flag a correction, ask which source backs a specific line, or suggest a study we should add. Please include the page and the exact claim you are referring to so we can check it against the record quickly.

## What we cannot help with

We cannot answer personal medical questions, recommend a dose, or advise whether any compound is appropriate for you. We are not a clinic, we employ no clinicians, and we provide no medical advice. We also do not sell, price, source, or supply PT-141 or bremelanotide in any form, and we cannot direct you to anyone who does.

For medical questions, consult a licensed healthcare professional who can evaluate your individual situation. For the regulatory and research record — what is approved, what is off-label, and what the studies measured — that is exactly what this site documents, and the [PT-141 references](/references) page links every source.

---

A carbon-spec datasheet of the PT-141 record — the one FDA-approved indication, the off-label boundary, and the unregulated research-chemical form each logged to source and read like a manufacturer's spec, with no clinic behind the sheet and nothing here dosed, priced, or sold.